Concord Wealth Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,067
Closed -$271K – 875
2024
Q4
$271K Buy
1,067
+1,044
+4,539% +$280K 0.04% 179
2024
Q3
$7.29K Buy
+23
New +$8.19K ﹤0.01% 588
2024
Q1
– Sell
-25
Closed -$11.5K – 877
2023
Q4
$11.5K Sell
25
-8
-24% -$3.94K ﹤0.01% 553
2023
Q3
$16.1K Buy
33
+4
+14% +$1.88K ﹤0.01% 544
2023
Q2
$13K Buy
29
+18
+164% +$9.06K ﹤0.01% 572
2023
Q1
$5.34K Sell
11
-12
-52% -$5.93K ﹤0.01% 661
2022
Q4
$11.8K Buy
+23
New +$12.1K ﹤0.01% 613
2022
Q3
– Sell
-36
Closed -$17K – 585
2022
Q2
$17K Buy
36
+8
+29% +$3.56K ﹤0.01% 574
2022
Q1
$12K Hold
28
– – ﹤0.01% 733
2021
Q4
$13K Buy
28
+21
+300% +$9.29K ﹤0.01% 733
2021
Q3
$3K Sell
7
-21
-75% -$8.91K ﹤0.01% 687
2021
Q2
$12K Buy
28
+22
+367% +$9.61K ﹤0.01% 593
2021
Q1
$3K Buy
+6
New +$2.4K ﹤0.01% 758

Other funds holding HUM

Concord Wealth Partners's HUM Position: Q1 2025 in Review

Concord Wealth Partners sold out of Humana (HUM) in Q1 2025, closing a stake of 1,067 shares — an estimated $271K sold.

Concord Wealth Partners first reported a position in HUM in Q1 2021 and held it in 13 quarters. The position peaked at $271K in Q4 2024. 903 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Concord Wealth Partners reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Concord Wealth Partners sold 1,067 Humana shares in Q1 2025, an estimated $271K.
  • Concord Wealth Partners first reported a position in Humana in Q1 2021 and held it in 13 quarters.
  • Concord Wealth Partners's Humana position peaked at $271K in Q4 2024.
  • 903 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Concord Wealth Partners's 13F filing for Q1 2025, filed 2 May 2025.